In Vivo Imaging Biomarkers in Mouse Models of Alzheimer's Disease: Are We Lost in Translation or Breaking Through? - CNRS - Centre national de la recherche scientifique Access content directly
Journal Articles International Journal of Alzheimer's Disease Year : 2010

In Vivo Imaging Biomarkers in Mouse Models of Alzheimer's Disease: Are We Lost in Translation or Breaking Through?

Abstract

Identification of biomarkers of Alzheimer's Disease (AD) is a critical priority to efficiently diagnose the patients, to stage the progression of neurodegeneration in living subjects, and to assess the effects of disease-modifier treatments. This paper addresses the development and usefulness of preclinical neuroimaging biomarkers of AD. It is today possible to image in vivo the brain of small rodents at high resolution and to detect the occurrence of macroscopic/microscopic lesions in these species, as well as of functional alterations reminiscent of AD pathology. We will outline three different types of imaging biomarkers that can be used in AD mouse models: biomarkers with clear translational potential, biomarkers that can serve as in vivo readouts (in particular in the context of drug discovery) exclusively for preclinical research, and finally biomarkers that constitute new tools for fundamental research on AD physiopathogeny.
Fichier principal
Vignette du fichier
2010BDelatour_Invivo imaging.pdf (2.03 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03234673 , version 1 (25-05-2021)

Identifiers

Cite

Benoît Delatour, Stéphane Epelbaum, Alexandra Petiet, Marc Dhenain. In Vivo Imaging Biomarkers in Mouse Models of Alzheimer's Disease: Are We Lost in Translation or Breaking Through?. International Journal of Alzheimer's Disease, 2010, 2010, pp.1 - 11. ⟨10.4061/2010/604853⟩. ⟨hal-03234673⟩
54 View
31 Download

Altmetric

Share

Gmail Facebook X LinkedIn More